论文部分内容阅读
我们挑选1984年入伍的乙肝病毒感染标志(HBVM)均阴性的新兵各200人,作为预防组和对照组。预防组每人每月注射乙肝疫苗一针,连续三针。注射第一针后的1、1、6、12个月采血测抗-HBs,阳性率分别为60％、96.2％、92.9％和84.6％。同时化验SGPT、HBsAg和抗-HB_c,均未发现不正常现象。而对照组在半年及一年复查有1/3及1/2新兵有HBVM阳性表现。证明乙肝疫苗安全、可靠、有效。为部队特种人员预防乙型肝炎提供了依据。
We selected 200 recruits recruited in 1984 who had a negative HBV infection marker (HBVM) of 200 each as a preventive group and a control group. Prevention group each injection of hepatitis B vaccine a needle per month, three consecutive injections. The positive rates of blood anti-HBs at 1, 1, 6 and 12 months after the first injection were 60%, 96.2%, 92.9% and 84.6%, respectively. At the same time test SGPT, HBsAg and anti-HBc, were not found abnormal. The control group in the semi-annual and one-year review of 1/3 and 1/2 recruits HBVM-positive. Hepatitis B vaccine proved safe, reliable and effective. Provide a basis for special forces personnel to prevent hepatitis B.